Fisher & Paykel Healthcare Corporation Limited (ASX:FPH)
33.45
-0.07 (-0.21%)
Jan 16, 2026, 4:10 PM AEST
ASX:FPH Market Cap
ASX:FPH has a market cap or net worth of 23 billion as of January 16, 2026. Its market cap has increased by 12.05% in one year.
Market Cap
23.00B
Enterprise Value
22.85B
Revenue
1.89B
Ranking
n/a
PE Ratio
60.03
Stock Price
33.45
Market Cap Chart
Since February 28, 1992, ASX:FPH's market cap has increased from 173.53M to 23.00B, an increase of 13,153.15%. That is a compound annual growth rate of 15.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 19.73B | 3.17% |
| Dec 31, 2025 | 19.12B | -6.12% |
| Dec 31, 2024 | 20.37B | 59.11% |
| Dec 29, 2023 | 12.80B | 4.87% |
| Dec 30, 2022 | 12.21B | -31.40% |
| Dec 31, 2021 | 17.79B | 0.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 83.64B |
| Pro Medicus | 21.90B |
| Cochlear | 17.45B |
| Sonic Healthcare | 11.45B |
| Ramsay Health Care | 8.25B |
| Ansell | 4.82B |
| Telix Pharmaceuticals | 3.76B |
| Mesoblast | 3.45B |